Advances in Therapeutics to Alleviate Cognitive Decline and Neuropsychiatric Symptoms of Alzheimer's Disease
J Li, A Haj Ebrahimi, AB Ali - International Journal of Molecular Sciences, 2024 - mdpi.com
Dementia exists as a 'progressive clinical syndrome of deteriorating mental function
significant enough to interfere with activities of daily living', with the most prevalent type of …
significant enough to interfere with activities of daily living', with the most prevalent type of …
A Recent Update on Pathophysiology and Therapeutic Interventions of Alzheimer's Disease
M Kashif, P Sivaprakasam, P Vijendra… - Current …, 2023 - ingentaconnect.com
Aim: Alzheimer's disease (AD) has been identified as a progressive brain disorder
associated with memory dysfunction and the accumulation of β-amyloid plaques and …
associated with memory dysfunction and the accumulation of β-amyloid plaques and …
[HTML][HTML] Alzheimer's disease: Insights and new prospects in disease pathophysiology, biomarkers and disease-modifying drugs
AR Monteiro, DJ Barbosa, F Remião, R Silva - Biochemical Pharmacology, 2023 - Elsevier
Alzheimer's disease (AD) is one of the most prevalent neurodegenerative diseases that
affect millions of people worldwide, with both prevalence and incidence increasing with age …
affect millions of people worldwide, with both prevalence and incidence increasing with age …
Impact of new drugs for therapeutic intervention in Alzheimer's disease
J Olloquequi, M Ettcheto, A Cano, E Sanchez-López… - 2022 - repositorio.uautonoma.cl
The increases in population ageing and growth are leading to a boosting in the number of
people living with dementia, Alzheimer's disease (AD) being the most common cause. In …
people living with dementia, Alzheimer's disease (AD) being the most common cause. In …
[HTML][HTML] Overview of therapeutic targets in management of dementia
Dementia is defined as a gradual cognitive impairment that interferes with everyday tasks,
and is a leading cause of dependency, disability, and mortality. According to the current …
and is a leading cause of dependency, disability, and mortality. According to the current …
Novel approaches for the treatment of Alzheimer's and Parkinson's disease
M Van Bulck, A Sierra-Magro, J Alarcon-Gil… - International journal of …, 2019 - mdpi.com
Neurodegenerative disorders affect around one billion people worldwide. They can arise
from a combination of genomic, epigenomic, metabolic, and environmental factors. Aging is …
from a combination of genomic, epigenomic, metabolic, and environmental factors. Aging is …
Therapeutic targeting strategies for early-to late-staged Alzheimer's disease
Alzheimer's disease (AD) is the most common cause of dementia, typically showing
progressive neurodegeneration in aging brains. The key signatures of the AD progression …
progressive neurodegeneration in aging brains. The key signatures of the AD progression …
[图书][B] Biological, Diagnostic and Therapeutic Advances in Alzheimer's Disease
GM Ashraf, A Alexiou - 2019 - Springer
Alzheimer's disease (AD) is still a hardly curable disease with several symptoms of
behavioral and cognitive impairments. Besides the altered protein levels and the side effects …
behavioral and cognitive impairments. Besides the altered protein levels and the side effects …
Molecular mechanisms of emerging therapeutic targets in Alzheimer's disease: a systematic review
T Premkumar, S Sajitha Lulu - Neurochemical Journal, 2022 - Springer
Alzheimer's disease (AD) is a severe cognitive impairment considered to be the leading
cause of dementia worldwide. The pathophysiology includes extracellular accumulation of …
cause of dementia worldwide. The pathophysiology includes extracellular accumulation of …
Neurodegenerative pathways in Alzheimer's disease: a review
Alzheimer's disease (AD) is a complex neurodegenerative disease that leads to insidious
deterioration of brain functions and is considered the sixth leading cause of death in the …
deterioration of brain functions and is considered the sixth leading cause of death in the …
相关搜索
- cognitive decline neuropsychiatric symptoms
- advances in therapeutics neuropsychiatric symptoms
- cognitive decline advances in therapeutics
- alzheimer's disease neuropsychiatric symptoms
- cognitive decline alzheimer's disease
- alzheimer's disease advances in therapeutics
- treatment of alzheimer parkinson's disease
- alzheimer's disease therapeutic interventions